Beate C. Litzenburger
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Growth Hormone and Insulin-like Growth Factors, Cancer, Hypoxia, and Metabolism, Bioinformatics and Genomic Networks, Genomics and Rare Diseases
Most-Cited Works
- → Constitutively Active Type I Insulin-Like Growth Factor Receptor Causes Transformation and Xenograft Growth of Immortalized Mammary Epithelial Cells and Is Accompanied by an Epithelial-to-Mesenchymal Transition Mediated by NF-κB and Snail(2007)247 cited
- → ALK: a tyrosine kinase target for cancer therapy(2017)188 cited
- → High IGF-IR Activity in Triple-Negative Breast Cancer Cell Lines and Tumorgrafts Correlates with Sensitivity to Anti–IGF-IR Therapy(2010)129 cited
- → The right drugs at the right time for the right patient: the MD Anderson precision oncology decision support platform(2015)72 cited
- → Precision Oncology Decision Support: Current Approaches and Strategies for the Future(2018)70 cited
- → BMS-536924 Reverses IGF-IR-Induced Transformation of Mammary Epithelial Cells and Causes Growth Inhibition and Polarization of MCF7 Cells(2008)59 cited
- → “Personalized Cancer Therapy”: A Publicly Available Precision Oncology Resource(2017)46 cited
- → Clinical Use of Precision Oncology Decision Support(2017)41 cited
- → Advances in Preventive Therapy for Estrogen-Receptor-Negative Breast Cancer(2014)40 cited
- → Use of a Targeted Exome Next-Generation Sequencing Panel Offers Therapeutic Opportunity and Clinical Benefit in a Subset of Patients With Advanced Cancers(2019)29 cited